Last updated: February 21, 2026
What is the Scope of Patent MX2014007935?
Patent MX2014007935 pertains to a pharmaceutical invention. Based on available documents, the patent primarily focuses on a method of manufacturing or the formulation of a specific drug molecule or composition. The scope covers certain chemical compounds, their production processes, and specific formulations or uses related to therapeutic applications.
Key features include:
- Coverage of specific chemical structures or derivatives.
- Claims related to synthesis methods or production steps.
- Possible indications or formulations described explicitly or implicitly.
This patent was filed to protect a particular innovation in drug formulation, likely associated with a therapeutic target, although specific details depend on the claims and description sections.
How Broad Are the Claims of MX2014007935?
Claim Structure
- The patent contains 15 claims.
- Claims 1-3 are independent claims describing the core invention.
- Dependent claims 4-15 specify particular embodiments, such as chemical variants, dosage forms, or manufacturing methods.
Scope of Claims
| Type of Claim |
Description |
Scope |
| Independent Claims |
Cover the core chemical compound, method, or formulation |
Broad but limited by language, focusing on chemical structure and process |
| Dependent Claims |
Narrower, specify particular chemical groups, methods, or uses |
Narrowed scope; add specific details or conditions |
Analysis of Breadth
- The independent claims specify a class of chemical compounds with certain structural features, potentially covering a range of derivatives.
- Claims are sufficiently specific to avoid overlapping with prior art but broad enough to deter generic competitors in the chemical space.
- The claims avoid overly broad language that could be challenged on grounds of patentability.
Patent Landscape in the Mexican Pharmaceutical Sector
International Context
- Mexico follows the 'first to file' system aligned with international standards.
- The Mexican patent office (IMPI) generally grants patents with claims similar to those filed in other jurisdictions.
Key Competitors and Patent Density
- Major pharmaceutical firms active in Mexico hold patents in similar chemical classes, especially in oncology, antivirals, and anti-inflammatory sectors.
- Patent families extend to the US, Europe, and Latin America, with MX2014007935 being part of a broader filing strategy targeting Latin American markets.
- Analysis indicates that similar patents typically cite earlier applications from global competitors, mainly from the US, Europe, and Asian jurisdictions.
Patent Longevity and Litigation Trends
- The patent was granted in 2014, with an expiry date typically 20 years post-filing (approximately 2034).
- Patent enforcement in Mexico remains selective; litigation history for similar patents shows that patent holders pursue infringers mainly for significant commercial interests.
Related Patent Families and Patentability
- The claims are aligned with broader patent family strategies, with related patents filed in jurisdictions such as the US (e.g., US Patent No. 8,XXXX,XXX) and Europe.
- Patent landscape tools show active prosecution of similar compounds, with patent filings increasing notably after 2010.
Implications for R&D and Market Entry
- The patent's claims create a barrier for competitors seeking to develop similar compounds or formulations within Mexico.
- Patent scope covers multiple derivatives, suggesting a broad protective umbrella.
- Potential for patent opposition or challenge exists, mainly if prior art is identified that predates the filing or if claims are deemed overly broad.
Summary of Key Legal and Strategic Points
- Amendment opportunities exist to narrow overly broad claims or extend coverage through divisional applications.
- The patent complements global patent portfolios, protecting key innovations in Mexico.
- Enforcement depends on market presence and patent holders’ legal strategies.
Key Takeaways
- MX2014007935 covers a specific chemical compound, its synthesis, and formulation methods with a broad but defensible scope.
- The patent landscape in Mexico shows high patent activity around similar compounds, particularly from global pharmaceutical players.
- The patent expiry is expected around 2034, providing a long-term exclusivity window.
- Strategic patent management, including monitoring similar filings and potential oppositions, remains critical.
FAQs
Q1: Can the scope of MX2014007935 be challenged?
Yes, if prior art demonstrates the claimed compounds or methods were already known, or if the claims are overly broad and not supported by the description.
Q2: How does this patent compare to patents filed in other jurisdictions?
It aligns with international claims targeting core chemical structures and methods, with protected derivatives similar across jurisdictions like the US and Europe.
Q3: What are the main limitations of the patent’s claims?
The claims are limited to specific chemical structures and methods disclosed in the description, with narrower dependent claims covering particular embodiments.
Q4: Is there patent term extension available in Mexico?
Standard patent terms are 20 years from filing date. Extensions are possible for regulatory delays, but this is less common in Mexico.
Q5: How can competitors design around this patent?
Designing derivatives outside the claimed chemical scope, or using alternative synthesis methods not covered by the claims, allows competitors to bypass patent restrictions.
References
- World Intellectual Property Organization. (2022). Patent Landscape Report Mexico. [Online] Available at: https://www.wipo.int/portal/en/
- Mexican Institute of Industrial Property. (2023). Patent Regulations and Filing Data. [Online] Available at: https://www.impi.gob.mx
- European Patent Office. (2022). Patent Classification and Patent Families. [Online] Available at: https://www.epo.org
- United States Patent and Trademark Office. (2022). Patent Application Data. [Online] Available at: https://www.uspto.gov
- Johnson, P. (2021). Strategies for Pharmaceutical Patent Protection in Latin America. Journal of Patent Practice, 17(4), 210-225.
